Advanced Biomed Inc. (NASDAQ:ADVB) Short Interest Up 73.5% in June

Advanced Biomed Inc. (NASDAQ:ADVB) was the target of a large growth in short interest during the month of June. As of June 30th, there was short interest totaling 15,397 shares, a growth of 73.5% from the June 15th total of 8,876 shares. Approximately 1.3% of the shares of the company are short sold. Based on an average trading volume of 14,727 shares, the days-to-cover ratio is presently 1.0 days.

Advanced Biomed Stock Performance

Shares of ADVB opened at $5.21 on Friday. The firm has a market cap of $8.60 million, a price-to-earnings ratio of 1.08 and a beta of 0.52. Advanced Biomed has a 52 week low of $3.61 and a 52 week high of $15.20. The firm has a 50-day moving average of $4.63.

Advanced Biomed (NASDAQ:ADVB) last issued its quarterly earnings data on Saturday, May 16th. The company reported ($0.38) earnings per share (EPS) for the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings downgraded Advanced Biomed from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, July 8th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has an average rating of “Sell”.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.